Key Facts
Type 1 diabetes is an autoimmune condition where the body's immune system destroys the insulin-producing cells in the pancreas. It typically onset in childhood or young adulthood but can occur at any age.
Pathophysiology
The condition is driven by a T-cell mediated autoimmune destruction of the beta cells in the Islets of Langerhans. This leads to an absolute insulin deficiency, meaning glucose cannot enter the cells for energy, resulting in severe hyperglycemia and ketosis.
Symptoms & Clinical Features
Diagnosis
Beyond standard glucose tests, diagnosis is confirmed by measuring C-peptide levels (which will be low or undetectable) and testing for pancreatic autoantibodies (GAD65, IA-2, ZnT8). These antibodies distinguish Type 1 from Type 2 or other forms of diabetes.
Diagnostic Pathway
Initial Screening
Symptom review and baseline hormonal blood tests.
Confirmatory Testing
Advanced diagnostic protocols (e.g., OGTT, MRI, Suppression tests).
Personalized Plan
Tailored treatment strategy based on clinical results.
Treatment & Management
Treatment requires lifelong insulin replacement therapy, either through multiple daily injections (MDI) or an insulin pump. Modern management emphasizes Continuous Glucose Monitoring (CGM) and "Closed-Loop" systems to maintain tight glycemic control and prevent Diabetic Ketoacidosis (DKA).
Personalized treatment plans for your health.